Compare GKOS & MRCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GKOS | MRCY |
|---|---|---|
| Founded | 1998 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.5B |
| IPO Year | 2015 | 1998 |
| Metric | GKOS | MRCY |
|---|---|---|
| Price | $116.08 | $69.78 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 7 |
| Target Price | ★ $125.54 | $76.43 |
| AVG Volume (30 Days) | ★ 865.8K | 662.9K |
| Earning Date | 10-29-2025 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $469,820,000.00 | ★ $932,798,000.00 |
| Revenue This Year | $31.15 | $6.47 |
| Revenue Next Year | $24.15 | $8.65 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 30.38 | 8.63 |
| 52 Week Low | $73.16 | $38.16 |
| 52 Week High | $163.71 | $85.33 |
| Indicator | GKOS | MRCY |
|---|---|---|
| Relative Strength Index (RSI) | 76.42 | 44.91 |
| Support Level | $105.88 | $68.81 |
| Resistance Level | $116.72 | $77.56 |
| Average True Range (ATR) | 3.26 | 2.60 |
| MACD | 0.07 | -0.05 |
| Stochastic Oscillator | 94.61 | 25.85 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.